Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc logo
JAZZ

Jazz Pharmaceuticals plc (JAZZ)

$156.540.24%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$155.28
Day's Range
$157.44
$119.64
52-Week Range
$169.98
1 month return9.29%
3 month return1.07%
1 year return27.58%
5 year return14.63%

Company Information

Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines that transform the lives of patients with serious diseases - often with limited or no options. Jazz Pharmaceuticals plc has a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. The company's focus is in neuroscience, including sleep and movement disorders, and in oncology, including hematologic and solid tumors. They actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries.
OrganizationJazz Pharmaceuticals plc
Employees3200
CEOMr. Bruce C. Cozadd
IndustryHealth Technology

Analyst Recommendation

based on 20 analysts ratings

Buy
90%
Buy
10%
Hold
0%
Sell

Based on 20 Wall street analysts offering stock ratings for Jazz Pharmaceuticals plc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 28.29%

Current

$156.54

Target

$200.83

Recommendation Trend

Based on 20 analyst

Current1M Ago3M Ago
Buy
18
21
21
Hold
2
3
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
9.9B
Book Value
$43.65
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-7.37
PEG Ratio
3.95
Wall Street Target Price
200.83

Valuation

Trailing PE0.0
Forward PE9.0
Price/Book (mrq)
3.57
Enterprise Value
14.7B
Enterprise Value/Revenue
4.11
Enterprise Value/Ebitda
16.83

Technicals

Beta
0.74
50 Day MA
139.85
200 Day MA
150.29

Sustainability

Rating Date2019-01-01
Total Esg
31.66
Total Esg Percentile
51.04
Environment Score4.18
Environment Score Percentile8.0
Social Score24.74
Social Score Percentile8.0
Governance Score13.74
GovernanceScorePercentile8.0
Controversy Level1.0

Institutional Holdings

Vanguard Group Inc

9.36%

JPMorgan Chase & Co

5.37%

State Street Corporation

3.64%

Wellington Management Company LLP

3.11%

LSV Asset Management

2.8%

FMR Inc

2.54%

Discover more

Frequently Asked Questions

What is Jazz Pharmaceuticals plc share price today?

Can Indians buy Jazz Pharmaceuticals plc shares?

How can I buy Jazz Pharmaceuticals plc shares from India?

Can Fractional shares of Jazz Pharmaceuticals plc be purchased?

What are the documents required to start investing in Jazz Pharmaceuticals plc stocks?

What are today’s High and Low prices of Jazz Pharmaceuticals plc?

What are today’s traded volumes of Jazz Pharmaceuticals plc?

What is today’s market capitalisation of Jazz Pharmaceuticals plc?

What is the 52 Week High and Low Range of Jazz Pharmaceuticals plc?

How much percentage Jazz Pharmaceuticals plc is down from its 52 Week High?

How much percentage Jazz Pharmaceuticals plc is up from its 52 Week low?

What are the historical returns of Jazz Pharmaceuticals plc?

Who is the Chief Executive Officer (CEO) of Jazz Pharmaceuticals plc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*